# Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma

> **NCT01892397** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 6 (actual)

## Conditions studied

- Brain Cancer

## Interventions

- **DEVICE:** Optune (NovoTTF-100A)

## Key facts

- **NCT ID:** NCT01892397
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-06
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-07-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01892397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01892397, "Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01892397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*